civil case between former Spaulding Clinical President
John Farrelly and CEO Randol Spaulding ended Friday,
resulting in the dismissal of the court trial, which was
scheduled to begin Monday.
Farrelly’s attorney Erik Eisenmann said “There was a
confidential agreement and the case was dismissed.” He
said no other information could be shared on the case.
Documents filed with the court stated, “It is hereby
ordered that this matter is dismissed on its merits,
with prejudice (permanently) and without costs to any
Farrelly accused Spaulding of terminating his employment
in an unjust manner. There has been disagreement about
whether Farrelly resigned or was terminated and what the
meaning of just cause for termination is.
specifically, Farrelly accused Spaulding of breach of
contract, breach of implied covenant of good faith and
fair dealing, promissory estoppel, unjust enrichment and
intentional interference with a contract.
than $240,000 was being sought from Farrelly, but it is
unclear what amount, if any, was given to Farrelly in
the settlement. Farrelly could not be reached for
comment and an email to Spaulding Clinical LLC was not
pair most recently appeared in court May 19 to discuss
motions prior to the trial. By Aug. 7, both parties
filed their proposed special verdicts in the case.
Questions asked in the special verdicts would have asked
the jury whether Farrelly had a contract with Spaulding,
if Spaulding interfered, whether the interference was
intentional, and if it caused harm to Farrelly. Among
other questions the jury would have also been asked how
much money they felt was owed to Farrelly, if any.